News Sentiment

PODD sentiment intelligence

Insulet Corporation news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 45 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Devices Read-through group
Latest close 161.28 Week of 10 Jul 2026
Weighted tone 45/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

72/100 classification confidence.

Company focus 48

directly relevant articles

Source quality 4

high-authority source matches

Trend context Trend inactive

-1.9% over one week, +7.7% over four weeks, trend inactive, and below fair value.

Latest direct headline Negative

Insulet (PODD) Stock May Be Above Fair Value On Recall Lawsuit Risk

Market Reaction

Balanced read

61/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 72/100 classification
One-week reaction -1.9% Price digesting
Trend fit Trend inactive 7.7% over four weeks
Fair value -31.0% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 13
Neutral 29
Negative 17

Relevance

Why the article matched

Direct first
Direct company coverage 48
Industry context 11
Sector context 0

Sources

Coverage mix

Publishers
Market source 20
simplywall.st 7
PR Newswire 6
GlobeNewswire 3
Stock Titan 3
ad-hoc-news.de 3
Morningstar 2
www.marketscreener.com 2

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 17
Regulatory and legal 15
Analyst action 5
Deals and strategy 2
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 59
GlobeNewswire Direct company coverage

Bronstein, Gewirtz & Grossman LLC Urges Insulet Corporation Investors to Act: Class Action Filed Alleging Investor Harm

Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and some of its officers for alleged violations of federal securities laws. The lawsuit seeks to recover damages for investors who purchased Insulet securities betwee

Tone
Negative 14/100
Event
Regulatory and legal
Published
16 Jul 2026 16:00
Source
GlobeNewswire
PR Newswire Direct company coverage

PODD Deadline Alert: SueWallSt Reminds Insulet Corporation (PODD) Investors of Securities Class Action Deadline on August 31, 2026

SueWallSt is notifying investors of Insulet Corporation (NASDAQ: PODD) that a class action lawsuit has been filed, with a lead plaintiff deadline of August 31, 2026. The lawsuit alleges that Insulet made misleading statements regarding its manufacturing quality and operational co

Tone
Neutral 50/100
Event
Regulatory and legal
Published
16 Jul 2026 14:39
Source
PR Newswire
PR Newswire Direct company coverage

Pomerantz Law Firm Announces the Filing of a Class Action Against Insulet Corporation and Certain Officers - PODD

Pomerantz LLP has filed a class action lawsuit against Insulet Corporation (NASDAQ: PODD) and certain officers, alleging violations of federal securities laws. The lawsuit claims that Insulet made materially false and misleading statements regarding defective manufacturing contro

Tone
Negative 18/100
Event
Regulatory and legal
Published
16 Jul 2026 14:00
Source
PR Newswire
GlobeNewswire Direct company coverage

Important Notice to Long-Term Shareholders of ADMA

Grabar Law Office is investigating potential breaches of fiduciary duties by officers and directors of ADMA Biologics, Inc. (ADMA), Insulet Corporation (PODD), Intuit Inc. (INTU), and Power Solutions International, Inc. (PSIX). The investigations center on alleged issues such as

Tone
Negative 30/100
Event
Regulatory and legal
Published
16 Jul 2026 12:13
Source
GlobeNewswire
Morningstar Direct company coverage

PODD UPCOMING DEADLINE: Levi & Korsinsky Alerts Insulet Corporation Stockholders of Securities Class Action - Contact the Firm

Levi & Korsinsky, LLP has issued an alert to investors of Insulet Corporation (NASDAQ: PODD) regarding a pending securities class action lawsuit. The lawsuit alleges that Insulet made misleading statements between February 21, 2025, and May 26, 2026, by downplaying the systemic n

Tone
Negative 28/100
Event
Regulatory and legal
Published
15 Jul 2026 14:10
Source
Morningstar
Trefis Direct company coverage

Same Industry, Less Money: What Insulet Offers That Intuitive Surgical Does Not

This article compares two medical technology companies, Intuitive Surgical (ISRG) and Insulet (PODD), highlighting their valuations, growth rates, and market positions. While ISRG commands a higher premium due to its dominant platform, profitability, and recurring revenue model,

Tone
Positive 62/100
Event
Earnings
Published
15 Jul 2026 13:38
Source
Trefis
MarketWatch Direct company coverage

Insulet Corp. stock outperforms competitors despite losses on the day

Insulet Corp. (PODD) stock notably underperformed its competitors despite an overall strong trading day for the stock market, seeing a 1.81% decline. This fall ended a three-day winning streak for the company's shares. Despite the daily loss, the article title suggests an overarc

Tone
Negative 38/100
Event
Market update
Published
14 Jul 2026 21:15
Source
MarketWatch
PR Newswire Direct company coverage

Lost Money on Insulet Corporation (PODD)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

The Gross Law Firm has issued a notice for shareholders of Insulet Corporation (NASDAQ: PODD) to join a class action lawsuit. Investors who purchased PODD shares between February 21, 2025, and May 26, 2026, are encouraged to contact the firm regarding potential lead plaintiff app

Tone
Negative 8/100
Event
Regulatory and legal
Published
14 Jul 2026 14:09
Source
PR Newswire
www.marketscreener.com Direct company coverage

PODD EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Insulet (PODD) Investors of Securities Class Action Lawsuit Deadline on August 31, 2026

Faruqi & Faruqi, LLP has reminded Insulet (PODD) investors that the deadline to seek the role of lead plaintiff in a securities class action lawsuit is August 31, 2026. The lawsuit alleges that Insulet made false or misleading statements regarding defective manufacturing controls

Tone
Negative 15/100
Event
Regulatory and legal
Published
14 Jul 2026 11:17
Source
www.marketscreener.com
PR Newswire Direct company coverage

PODD Court News: Insulet Class Action Lawsuit Alleges Securities Fraud on behalf of Investors with Losses

Bleichmar Fonti & Auld LLP has filed a class action lawsuit against Insulet Corporation (NASDAQ: PODD) for securities fraud, alleging misrepresentation regarding the safety of its Omnipod products. The lawsuit comes after significant stock drops on March 12, 2026, and May 26, 202

Tone
Negative 15/100
Event
Regulatory and legal
Published
14 Jul 2026 10:17
Source
PR Newswire
Stock Titan Direct company coverage

Lila Moss narrates a new sleep story for the diabetes community

Insulet Corporation has partnered with Calm to launch "The Mind in Range Collection," a suite of free mindfulness tools for the diabetes community, including meditations, breathing exercises, and a sleep story narrated by Lila Moss. This initiative emphasizes the importance of me

Tone
Positive 67/100
Event
Market update
Published
14 Jul 2026 07:02
Source
Stock Titan
Market source Direct company coverage

Insulet Partners with Calm to Bring Mindfulness and Well-Being Tools to the Diabetes Community, Featuring a New Sleep Story Narrated by Lila Moss

Insulet Corporation announced a global partnership with Calm to provide emotional well-being resources for the diabetes community, including those living with diabetes, their caregivers, and healthcare professionals. This initiative, called "The Mind in Range Collection," feature

Tone
Positive 75/100
Event
Deals and strategy
Published
14 Jul 2026 07:00
Source
Market source
Morningstar Direct company coverage

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit

Rosen Law Firm is reminding purchasers of Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025, and May 26, 2026, about the August 31, 2026, deadline to serve as lead plaintiff in a securities fraud lawsuit. The lawsuit alleges that Insulet made false or mislea

Tone
Negative 29/100
Event
Regulatory and legal
Published
13 Jul 2026 21:37
Source
Morningstar
PR Newswire Direct company coverage

PODD Investors Have Rights - If You Lost Money Investing in Insulet Corporation Contact Robbins LLP for Information About Recovering Your Losses

Robbins LLP is reminding investors who purchased Insulet Corporation (NASDAQ: PODD) securities between February 21, 2025, and May 26, 2026, about a class action lawsuit filed on their behalf. The suit alleges that Insulet misled investors regarding product viability due to defect

Tone
Negative 28/100
Event
Regulatory and legal
Published
13 Jul 2026 21:13
Source
PR Newswire
GlobeNewswire Direct company coverage

PODD DEADLINE: Levi & Korsinsky Reminds Insulet Corporation Investors of Upcoming Securities Class Action Deadline Alert: Claims Focus on Alleged Defective Cannula Manufacturing That Caused Insulin Under-Delivery in Millions of Omnipod Devices

Levi & Korsinsky, LLP is reminding purchasers of Insulet Corporation (NASDAQ: PODD) securities about an upcoming deadline for a class action lawsuit. The lawsuit alleges that Insulet failed to disclose defective cannula manufacturing that led to insulin under-delivery in millions

Tone
Negative 29/100
Event
Regulatory and legal
Published
13 Jul 2026 14:00
Source
GlobeNewswire
www.marketscreener.com Direct company coverage

Truist Lowers Price Target on Insulet to $210 From $219, Keeps Buy Rating

Truist has lowered its price target for Insulet (NASDAQ: PODD) to $210 from $219, while maintaining a "Buy" rating on the stock. This adjustment follows a similar action by RBC, which also recently reduced its price target for Insulet. The article highlights other recent analyst

Tone
Negative 39/100
Event
Analyst action
Published
13 Jul 2026 12:09
Source
www.marketscreener.com
PR Newswire Direct company coverage

PODD Investors Have Opportunity to Lead Insulet Corporation Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm has announced a class action lawsuit against Insulet Corporation (NASDAQ: PODD) for alleged securities fraud, encouraging investors who purchased securities between February 21, 2025, and May 26, 2026, to participate. The lawsuit claims Insulet made false and

Tone
Negative 26/100
Event
Regulatory and legal
Published
13 Jul 2026 03:58
Source
PR Newswire
Quartr Direct company coverage

Insulet (PODD) Investor presentation Summary

Insulet's investor presentation summary outlines its strategic vision to reduce the daily burden of diabetes through innovation. The company holds a leading position in the automated insulin delivery (AID) market in the U.S. and Europe, boasting significant revenue and EPS growth

Tone
Positive 92/100
Event
Earnings
Published
13 Jul 2026 02:33
Source
Quartr
Quiver Quantitative Direct company coverage

Lobbying Update: $60,000 of INSULET CORPORATION lobbying was just disclosed

Insulet Corporation (PODD) recently disclosed $60,000 in lobbying expenditures for Q2 2026, focusing on diabetes care education. The company has also seen recent congressional sales of its stock, significant insider purchases, and varied hedge fund activity. Wall Street analysts

Tone
Neutral 50/100
Event
Market update
Published
13 Jul 2026 02:10
Source
Quiver Quantitative